首页> 美国卫生研究院文献>Molecular Medicine Reports >Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcoma
【2h】

Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcoma

机译:成纤维细胞生长因子受体1促进MG63细胞增殖并与骨肉瘤中细胞周期蛋白依赖性激酶1的表达增加有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Osteosarcoma is the most common type of malignant bone tumor in adolescents and young adults. However, current understanding of osteosarcomagenesis remains limited. In the present study, the role of fibroblast growth factor receptor 1 (FGFR1) in human osteosarcoma cell proliferation was investigated, and the possible pathways that contribute to FGFR1-mediated osteosarcoma cell proliferation were examined using microarray analysis. The expression of FGFR1 in osteosarcoma tissues was assessed by reverse transcription-quantitative polymerase chain reaction and immunohistochemistry. The results demonstrated that FGFR1 was markedly increased in osteosarcoma tissues, and that the overexpression of FGFR1 in MG63 cells significantly promoted cell proliferation, as observed using the cell viability assay. In addition, FGFR1-mediated cell proliferation was closely associated with cell cycle re-distribution, as determined by microarray analysis. Western blotting identified that the expression of cyclin-dependent kinase 1 (CDK1) was correspondingly increased in response to the overexpression of FGFR1. These results indicated that FGFR1 contributes to cell proliferation in osteosarcoma MG63 cells, and FGFR1 mediated cell proliferation may be attributed to the regulation of the cell cycle regulator, CDK1. These findings provide evidence to support the potential use of molecule target therapy against FGFR1 as a promising strategy in osteosarcoma treatment and prevention.
机译:骨肉瘤是青少年和年轻人中最常见的恶性骨肿瘤类型。但是,目前对骨肉瘤的认识仍然有限。在本研究中,研究了成纤维细胞生长因子受体1(FGFR1)在人骨肉瘤细胞增殖中的作用,并使用微阵列分析检查了可能促进FGFR1介导的骨肉瘤细胞增殖的途径。通过逆转录定量聚合酶链反应和免疫组织化学评估FGFR1在骨肉瘤组织中的表达。结果表明,骨肉瘤组织中FGFR1明显增加,而MG63细胞中FGFR1的过表达显着促进了细胞增殖,如使用细胞生存力测定法所观察到的。此外,通过微阵列分析确定,FGFR1介导的细胞增殖与细胞周期的重新分布密切相关。 Western blotting证实,细胞周期蛋白依赖性激酶1(CDK1)的表达相应地响应FGFR1的过表达而增加。这些结果表明,FGFR1有助于骨肉瘤MG63细胞的细胞增殖,而FGFR1介导的细胞增殖可能归因于细胞周期调节剂CDK1的调节。这些发现提供了证据支持针对FGFR1的分子靶标疗法作为骨肉瘤治疗和预防中的一种有前途的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号